학술논문
Long-Term and Low-Grade Safety Results of a Phase III Study (PARAMOUNT): Maintenance Pemetrexed Plus Best Supportive Care Versus Placebo Plus Best Supportive Care Immediately After Induction Treatment With Pemetrexed Plus Cisplatin for Advanced Nonsquamous Non–Small-Cell Lung Cancer
Document Type
Article
Author
Source
In Clinical Lung Cancer November 2014 15(6):418-425
Subject
Language
ISSN
1525-7304